Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2020 Dec 30:14:100745.
doi: 10.1016/j.bonr.2020.100745. eCollection 2021 Jun.

Imaging technologies in the differential diagnosis and follow-up of brown tumor in primary hyperparathyroidism: Case report and review of the literature

Davide Diacinti  1   2 , Cristiana Cipriani  3 , Federica Biamonte  1   3 , Jessica Pepe  3 , Luciano Colangelo  1   3 , Endi Kripa  4 , Antonio Iannacone  4 , Martina Orlandi  4 , Vito Guarnieri  5 , Daniele Diacinti  4 , Salvatore Minisola  3
Affiliations
Case Reports

Imaging technologies in the differential diagnosis and follow-up of brown tumor in primary hyperparathyroidism: Case report and review of the literature

Davide Diacinti et al. Bone Rep. .

Abstract

Brown tumors are osteolytic lesions associated with hyperparathyroidism (HPT). They may involve various skeletal segments, but rarely the cranio-facial bones. We report a case of a young boy with a swelling of the jaw secondary to a brown tumor presenting as the first manifestation of primary HPT (PHPT). He was found to have brown tumor located in the skull, as well. Different imaging technologies were employed for the diagnosis and follow-up after parathyroidectomy. We enclose a review of the literature on the employment of such imaging technologies in the differential diagnosis of osteolytic lesions. A multidisciplinary approach comprising clinical, laboratory and imaging findings is essential for the differential diagnosis of brown tumor in PHPT.

Keywords: Brown tumor; MRI; Parathyroid adenoma; Primary hyperparathyroidism.

PubMed Disclaimer

Conflict of interest statement

S.M. served as speaker for Abiogen, Amgen, Bruno Farmaceutici, Diasorin, Eli Lilly, Shire, Sandoz, Takeda. He served in advisory board of Abiogen, Kyowa Kirin, Pfizer, UCB. All other authors declare no conflict of interests.

Figures

Fig. 1
Fig. 1
a) Ultrasound image showing the parathyroid adenoma as an oblong hypo-echoic and capsulated lesion with signal color-Doppler of monopolar vascular pattern referred to as the arc or rim sign, posterior-inferiorly to the left thyroid lobe; b) Axial T2 IDEAL Fat Suppressed MRI image depicting hyperintense parathyroid adenoma posterior-inferiorly to the left thyroid lobe, and separated from the thyroid gland (arrow); c) 99-mTc sestamibi scan demonstrating a residual uptake on left side 2 h after the radiotracer administration (arrow); d) X-ray image of the skull showing an osteolytic lesion with lobulated margin in the right parietal bone (arrow); e) Sagittal post-contrast T1-weighted MRI image showing enhancement of the parathyroid adenoma and of the jaw brown tumor (arrow); f) 99-mTc scan demonstrating uptake of the jaw bone and of the right parietal lobe of the skull (arrow).
Fig. 2
Fig. 2
Six-month post-surgery images. a) Parathyroid adenoma; b) Axial T2 IDEAL Fat Suppressed MRI image showing surgical resection of the parathyroid adenoma and of the left thyroid lobe (arrow); c) Sagittal post-contrast T1-weighted MRI showing almost absent contrast enhancement of the brown tumor, excluding persistence of contrast peripheral enhancement in some areas of the lesion (arrow); d) X-ray image of the skull showing no evidence of the previous osteolytic lesion in the right parietal bone.
See this image and copyright information in PMC

References

    1. Argiro R., Diacinti D., Sacconi B., Iannarelli A., Diacinti D., Cipriani C., Pisani D., Romagnoli E., Biffoni M., Di Gioia C., Pepe J., Bezzi M., Letizia C., Minisola S., Catalano C. Diagnostic accuracy of 3T magnetic resonance imaging in the preoperative localisation of parathyroid adenomas: comparison with ultrasound and 99mTc-sestamibi scans. Eur. Radiol. 2018;28:4900–4908. - PubMed
    1. Bilezikian J.P., Bandeira L., Khan A., Cusano N.E. Hyperparathyroidism. Lancet. 2018;391:168–178. - PubMed
    1. Brabyn P., Capote A., Belloti M., Zylberberg I. Hyperparathyroidism diagnosed due to Brown tumors of the jaw: a case report and literature review. Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons. 2017;75:2162–2169. - PubMed
    1. Carpten JD, Robbins CM, Villablanca A, Forsberg L, Presciuttini S, Bailey-Wilson J, Simonds WF, Gillanders EM, Kennedy AM, Chen JD, Agarwal SK, Sood R, Jones MP, Moses TY, Haven C, Petillo D, Leotlela PD, Harding B, Cameron D, Pannett AA, Hoog A, Heath H, 3rd, James-Newton LA, Robinson B, Zarbo RJ, Cavaco BM, Wassif W, Perrier ND, Rosen IB, Kristoffersson U, Turnpenny PD, Farnebo LO, Besser GM, Jackson CE, Morreau H, Trent JM, Thakker RV, Marx SJ, Teh BT, Larsson C, Hobbs MR (2002) HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome. Nature genetics 32:676–680. - PubMed
    1. Cebesoy O., Karakok M., Arpacioglu O., Baltaci E.T. Brown tumor with atypical localization in a normocalcemic patient. Arch. Orthop. Trauma Surg. 2007;127:577–580. - PubMed

Publication types

LinkOut - more resources